Autocrine IL-8 and VEGF mediate epithelial-mesenchymal transition and invasiveness via p38/JNK-ATF-2 signalling in A549 lung cancer cells

Cell Signal. 2013 Sep;25(9):1780-91. doi: 10.1016/j.cellsig.2013.05.025. Epub 2013 May 25.

Abstract

Soluble factors in tumour microenvironment play a major role in modulating the metastatic potential of cancer cells. Herein, we investigated the effect of autocrine cytokines and growth factors in the form of self-conditioned medium (CM) on A549 lung carcinoma cells. We demonstrated that CM induced morphological and molecular changes associated with epithelial-mesenchymal transition viz change in shape from cuboidal to spindle, actin cytoskeleton remodelling, upregulation of vimentin and downregulation of E-cadherin etc. These changes were accompanied with enhanced motility, invasion, anchorage-independent growth and anoikis-resistance. Amongst the different factors of CM, IL-8 and VEGF were found to play a major role in the CM-induced motility and invasion. In the intracellular signalling cascade, CM triggered phosphorylation of JNK and p38 which was associated with the CM-enhanced invasiveness. In CM-treated cells, activated p38 and JNK further activated ATF-2 (Activating Transcription Factor-2) and knock-down of ATF-2 abrogated the CM-induced invasiveness, suggesting the signal transduction along the p38/JNK-ATF-2 axis. Furthermore, neutralising IL-8 and VEGF in CM, significantly abrogated CM-induced phosphorylation of ATF-2. Conversely, exogenous addition of these individual cytokines in plain medium, increased the activation of ATF-2 and invasiveness marginally. However, when added in combination these cytokines (IL-8 and VEGF) resulted in drastic increase in ATF-2 phosphorylation and subsequent invasiveness suggesting their synergetic interplay in the observed phenomenon. Taken together, our results identify IL-8/VEGF induced JNK/p38-ATF-2 as a novel pro-invasive pathway, which may be explored as potential therapeutic target to circumvent the invasiveness of lung malignancies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activating Transcription Factor 2 / immunology*
  • Cell Adhesion
  • Cell Line, Tumor
  • Cell Movement
  • Epithelial-Mesenchymal Transition*
  • Humans
  • Interleukin-8 / immunology*
  • JNK Mitogen-Activated Protein Kinases / immunology*
  • Lung / immunology
  • Lung / pathology
  • Lung Neoplasms / immunology*
  • Lung Neoplasms / pathology
  • Neoplasm Invasiveness / immunology
  • Neoplasm Invasiveness / pathology
  • Signal Transduction
  • Vascular Endothelial Growth Factor A / immunology*
  • p38 Mitogen-Activated Protein Kinases / immunology*

Substances

  • ATF2 protein, human
  • Activating Transcription Factor 2
  • Interleukin-8
  • Vascular Endothelial Growth Factor A
  • JNK Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases